Abstract
The versatility and potential of reductive cyclisation as a route to 5-membered N-heterocyclic structures of diverse complexity is demonstrated through selected examples.
Keywords: heterocycles, cycloaddition, leimgruber-batcho synthesis, reducing agents, cross-coupling reaction, cytotoxicity, human lung cancer
Current Organic Chemistry
Title: Reductive Cyclisation in the Synthesis of 5-Membered N-Heterocycles
Volume: 8 Issue: 16
Author(s): Petros G. Tsoungas and Andreas I. Diplas
Affiliation:
Keywords: heterocycles, cycloaddition, leimgruber-batcho synthesis, reducing agents, cross-coupling reaction, cytotoxicity, human lung cancer
Abstract: The versatility and potential of reductive cyclisation as a route to 5-membered N-heterocyclic structures of diverse complexity is demonstrated through selected examples.
Export Options
About this article
Cite this article as:
Tsoungas G. Petros and Diplas I. Andreas, Reductive Cyclisation in the Synthesis of 5-Membered N-Heterocycles, Current Organic Chemistry 2004; 8 (16) . https://dx.doi.org/10.2174/1385272043369755
DOI https://dx.doi.org/10.2174/1385272043369755 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Human Platelet Acetylcholinesterase Inhibition by Cyclophosphamide: A Combined Experimental and Computational Approach
CNS & Neurological Disorders - Drug Targets Tyrosine Kinase Inhibitors
Current Cancer Drug Targets Overview of Mechanisms of Cancer Stem Cell Drug Resistance
Current Signal Transduction Therapy The Use of Fas Ligand, TRAIL and Bax in Gene Therapy of Prostate Cancer
Current Gene Therapy B Cell Modulation Strategies in Autoimmunity: The SLE Example
Current Pharmaceutical Design Advances in Photodynamic Therapy of Cancer
Current Cancer Therapy Reviews Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
Current Cancer Drug Targets Molecular Dynamics in Esophageal Adenocarcinoma: Who’s in Control?
Current Cancer Drug Targets Electrochemical Study of DNA Damaged by Oxidation Stress
Combinatorial Chemistry & High Throughput Screening Lung Cancer Surgery in Patients with Chronic Obstructive Pulmonary Disease (COPD): Surgical Selection Challenges and Clinical Outcomes
Current Respiratory Medicine Reviews Nifurtimox Hampered the Progression of Astroglioma <i>In vivo Via</i> Manipulating the AKT-GSK3β axis
Current Molecular Medicine The Radio-Sensitizing Effect of Pharmacological Concentration of Ascorbic Acid on Human Pancreatic Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Current Insights into Interethnic Variability in Testicular Cancers: Population Pharmacogenetics, Clinical Trials, Genetic Basis of Chemotherapy- Induced Toxicities and Molecular Signal Transduction
Current Topics in Medicinal Chemistry P53 Gene Therapy Sensitizes Resistant Breast Cancer Cells to Doxorubicin Chemotherapy
Drug Delivery Letters Microfluidic Devices for Circulating Tumor Cells Isolation and Subsequent Analysis
Current Pharmaceutical Biotechnology TGF Beta Inhibition for Cancer Therapy
Current Cancer Drug Targets Occurrence and Biological Properties of Sphingolipids - A Review
Current Nutrition & Food Science Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment
Current Cancer Drug Targets Distinctive Cellular Roles for Novel Protein Kinase C Isoenzymes
Current Pharmaceutical Design